-+ 0.00%
-+ 0.00%
-+ 0.00%

NewcelX prices USD 1.4 million private placement at USD 4.03 per share

PUBT·07/31/2026 13:00:36
Listen to the news
NewcelX prices USD 1.4 million private placement at USD 4.03 per share
  • NewcelX priced a USD 1.4 million private placement at USD 4.03 per share, a 20% premium to the July 30 close.
  • Deal covers 347,134 common shares, with warrants for 347,134 shares at a USD 4.44 exercise price.
  • Closing targeted for about Aug. 14, subject to customary conditions.
  • Proceeds earmarked to advance NCEL-101 for type 1 diabetes, with Eledon Pharmaceuticals, with remaining funds for working capital.
  • Securities to be issued in an unregistered offering under Section 4(a)(2) and Regulation D.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NLS Pharmaceutics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310900PRIMZONEFULLFEED9801621) on July 31, 2026, and is solely responsible for the information contained therein.